{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:09:16Z","timestamp":1781737756071,"version":"3.54.5"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"vor","delay-in-days":1515,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Amiodarone reduces the incidence of atrial fibrillation (AF) following coronary artery bypass surgery; however, the benefit of perioperative amiodarone in patients undergoing septal myectomy (SM) for obstructive hypertrophic cardiomyopathy (oHCM) has not been studied. We hypothesized that prophylactic amiodarone would reduce the incidence of postoperative AF (POAF) following SM for oHCM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and Results<\/jats:title>\n                    <jats:p>A single-centre, pre-post intervention open-label study of oral amiodarone (200 mg twice daily starting 7 days preoperatively and 200 mg once daily continuing for 30 days postoperatively) in patients without prior AF undergoing SM for oHCM from 2014 to 2018. The primary outcome was incident AF within 30 days. Secondary outcomes were unplanned readmission, AF treatment, total and intensive care unit (ICU) length of stay (LOS), and pacemaker implantation for high-grade atrioventricular (AV) block. 61 patients met inclusion criteria with 34 (55.8%) in the pre-intervention (control) group and 27 (44.2%) in the post-intervention (amiodarone) group. The incidence of POAF was 11.0% in the amiodarone group compared with 38.2% in the control group (P = 0.017). After adjusting for age, amiodarone was associated with less POAF [adjusted odds ratio (aOR) 0.21; 95% confidence interval (CI) 0.05, 0.76; P = 0.016]. ICU (2 days [IQR 1, 4] vs. 3 days [IQR 2, 4]; P = 0.165) and total (6 days [IQR 5, 6] vs. 6 days [IQR 5, 7]; P = 0.165) LOS were similar, as was the rate of pacemaker implantation (7.4% vs. 8.3%, P &amp;gt; 0.999). There were no adverse events associated with amiodarone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Perioperative oral amiodarone is safe and was associated with lower incidence of POAF following SM for oHCM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.13662","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T02:02:54Z","timestamp":1635386574000},"page":"4791-4799","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Perioperative Amiodarone to Prevent Atrial Fibrillation After Septal Myectomy in obstrUctive hypeRtroPHic Cardiomyopathy"],"prefix":"10.1093","volume":"8","author":[{"given":"Evan F.","family":"Shalen","sequence":"first","affiliation":[{"name":"The Hypertrophic Cardiomyopathy Center, Knight Cardiovascular Institute, Oregon Health & Science University , Portland, Oregon ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Heitner","sequence":"additional","affiliation":[{"name":"The Hypertrophic Cardiomyopathy Center, Knight Cardiovascular Institute, Oregon Health & Science University , Portland, Oregon ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana","family":"Al-Rashdan","sequence":"additional","affiliation":[{"name":"The Hypertrophic Cardiomyopathy Center, Knight Cardiovascular Institute, Oregon Health & Science University , Portland, Oregon ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyhaneh","family":"Akhavein","sequence":"additional","affiliation":[{"name":"The Hypertrophic Cardiomyopathy Center, Knight Cardiovascular Institute, Oregon Health & Science University , Portland, Oregon ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam R.","family":"Elman","sequence":"additional","affiliation":[{"name":"School of Public Health, Oregon Health & Science University, Portland State University , Portland, Oregon ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Fischer","sequence":"additional","affiliation":[{"name":"The Hypertrophic Cardiomyopathy Center, Knight Cardiovascular Institute, Oregon Health & Science University , Portland, Oregon ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy Q.","family":"Lin","sequence":"additional","affiliation":[{"name":"The Hypertrophic Cardiomyopathy Center, Knight Cardiovascular Institute, Oregon Health & Science University , Portland, Oregon ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Mannello","sequence":"additional","affiliation":[{"name":"The Hypertrophic Cardiomyopathy Center, Knight Cardiovascular Institute, Oregon Health & Science University , Portland, Oregon ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Nazer","sequence":"additional","affiliation":[{"name":"The Hypertrophic Cardiomyopathy Center, Knight Cardiovascular Institute, Oregon Health & Science University , Portland, Oregon ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard K.","family":"Song","sequence":"additional","affiliation":[{"name":"The Hypertrophic Cardiomyopathy Center, Knight Cardiovascular Institute, Oregon Health & Science University , Portland, Oregon ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6390-6526","authenticated-orcid":false,"given":"Ahmad","family":"Masri","sequence":"additional","affiliation":[{"name":"The Hypertrophic Cardiomyopathy Center, Knight Cardiovascular Institute, Oregon Health & Science University , Portland, Oregon ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,10,27]]},"reference":[{"key":"2026012114192349700_ehf213662-bib-0001","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012250","article-title":"Prevalence of unexplained left ventricular hypertrophy by cardiac magnetic resonance imaging in MESA","volume":"8","author":"Massera","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2026012114192349700_ehf213662-bib-0002","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults. echocardiographic analysis of 4111 subjects in the CARDIA study. coronary artery risk development in (Young) adults","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"key":"2026012114192349700_ehf213662-bib-0003","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/hc4601.097997","article-title":"Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy","volume":"104","author":"Olivotto","year":"2001","journal-title":"Circulation"},{"key":"2026012114192349700_ehf213662-bib-0004","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0735-1097(01)01727-2","article-title":"Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy","volume":"39","author":"Maron","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026012114192349700_ehf213662-bib-0005","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/heartjnl-2013-304276","article-title":"Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review","volume":"100","author":"Guttmann","year":"2014","journal-title":"Heart"},{"key":"2026012114192349700_ehf213662-bib-0006","doi-asserted-by":"crossref","first-page":"36","DOI":"10.21037\/cdt.2016.11.23","article-title":"Outcomes in hypertrophic cardiomyopathy patients with and without atrial fibrillation: a survival meta-analysis","volume":"7","author":"Masri","year":"2017","journal-title":"Cardiovasc Diagn Ther"},{"key":"2026012114192349700_ehf213662-bib-0007","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001002","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population","volume":"3","author":"Siontis","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"2026012114192349700_ehf213662-bib-0008","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jacc.2003.11.023","article-title":"Postoperative atrial fibrillation and mortality after coronary artery bypass surgery","volume":"43","author":"Villareal","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026012114192349700_ehf213662-bib-0009","first-page":"627","article-title":"Postoperative atrial fibrillation: incidence, mechanisms, and clinical correlates","volume":"32","author":"Yadava","year":"2014","journal-title":"Cardiol Clin"},{"key":"2026012114192349700_ehf213662-bib-0010","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/ejcts\/ezx039","article-title":"Postoperative atrial fibrillation following cardiac surgery: a persistent complication","volume":"52","author":"Greenberg","year":"2017","journal-title":"Eur J Cardiothorac Surg Oxford Academic"},{"key":"2026012114192349700_ehf213662-bib-0011","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1001\/jama.294.24.3093","article-title":"Prophylactic Oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair: PAPABEAR: a randomized controlled trial","volume":"294","author":"Mitchell","year":"2005","journal-title":"JAMA"},{"key":"2026012114192349700_ehf213662-bib-0012","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.jacc.2011.06.011","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, american Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons","volume":"58","author":"Gersh","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026012114192349700_ehf213662-bib-0013","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.athoracsur.2018.04.026","article-title":"Routine papillary muscle realignment and septal myectomy for obstructive hypertrophic cardiomyopathy","volume":"106","author":"Song","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"2026012114192349700_ehf213662-bib-0014","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"key":"2026012114192349700_ehf213662-bib-0015","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1002\/sim.7273","article-title":"Firth's logistic regression with rare events: accurate effect estimates and predictions?","volume":"36","author":"Puhr","year":"2017","journal-title":"Stat Med"},{"key":"2026012114192349700_ehf213662-bib-0016","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","article-title":"Bias reduction of maximum likelihood estimates","volume":"80","author":"Firth","year":"1993","journal-title":"Biometrika"},{"key":"2026012114192349700_ehf213662-bib-0017","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJM199712183372501","article-title":"Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery","volume":"337","author":"Daoud","year":"1997","journal-title":"N Engl J Med"},{"key":"2026012114192349700_ehf213662-bib-0018","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ahj.2019.11.020","article-title":"Comparison of expected and observed outcomes for septal myectomy in hypertrophic obstructive cardiomyopathy","volume":"221","author":"Geske","year":"2020","journal-title":"Am Heart J"},{"key":"2026012114192349700_ehf213662-bib-0019","doi-asserted-by":"crossref","first-page":"63","DOI":"10.15420\/aer.2017:4:2","article-title":"Atrial fibrillation and anticoagulation in hypertrophic cardiomyopathy","volume":"6","author":"Camm","year":"2017","journal-title":"Arrhythmia Electrophysiol Rev"},{"key":"2026012114192349700_ehf213662-bib-0020","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1016\/j.jacc.2014.03.021","article-title":"2014 AHA\/ACC\/HRS guideline for the Management of Patients with Atrial Fibrillation: executive summary: a report of the american College of Cardiology\/American Heart Association task force on practice guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026012114192349700_ehf213662-bib-0021","first-page":"1648","article-title":"Long-Term Outcomes of Secondary Atrial Fibrillation in the Community","volume":"131","author":"Lubitz Steven","year":"2015","journal-title":"Circulation American Heart Association"},{"key":"2026012114192349700_ehf213662-bib-0022","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.athoracsur.2006.06.032","article-title":"Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery: a meta-analysis","volume":"82","author":"Bagshaw","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"2026012114192349700_ehf213662-bib-0023","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.amjcard.2014.07.075","article-title":"Results of ventricular septal myectomy and hypertrophic cardiomyopathy (from Nationwide inpatient sample [1998\u20132010])","volume":"114","author":"Panaich","year":"2014","journal-title":"Am J Cardiol"},{"key":"2026012114192349700_ehf213662-bib-0024","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jacc.2019.05.053","article-title":"Conduction abnormalities and long-term mortality following septal myectomy in patients with obstructive hypertrophic cardiomyopathy","volume":"74","author":"Cui","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026012114192349700_ehf213662-bib-0025","article-title":"Use of intraoperative dobutamine stress echocardiography on outcomes of septal myectomy","author":"Bonanno","year":"2020","journal-title":"Semin Thorac Cardiovasc Surg"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.13662","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.13662","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/8\/6\/4791\/65569319\/eschf_8_6_4791.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/8\/6\/4791\/65569319\/eschf_8_6_4791.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:23:09Z","timestamp":1769023389000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/8\/6\/4791\/8343703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,27]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,10,27]]},"published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.13662","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12]]},"published":{"date-parts":[[2021,10,27]]},"assertion":[{"value":"2021-04-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}